China Sky One Medical, Inc., announced today that its subsidiary, Heilongjiang Tianlong Pharmaceuticals, has obtained approvals for two new drugs; Oxymetazoline Hydrochloride Nasal Drops and Taurine Eye Drops, from the SFDA.
Oxymetazoline Hydrochloride Nasal Drops is approved for the treatment of acute and chronic rhinitis, sinusitis and allergic rhinitis. Taurine Eye Drops is approved for the treatment of acute and chronic conjunctivitis. The incidences of these diseases in China are extremely high. This is especially true in regions with colder weather as well as coastal regions.
The details can be read here.
No comments:
Post a Comment